Fundraising Fox
Supira Medical
Campbell, US · Delaware corporation · 140 employees on LinkedIn · 8 known investors
Find your way into Supira Medical
Sign up to see every warm intro you have to Supira Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Supira Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock. It is a cardiovascular medical device company formed by the Shifamed innovation hub.
Founders & leadership
NS
Nitin SalunkePresident & CEO; Member of the Board of DirectorsNitin Salunke is a medical device executive with three decades of experience in development and leadership of Class II and III cardiovascular and neurovascular products across technical, clinical, operations, and general management roles. His background spans cardiology, structural heart, endovascular, and mechanical circulatory support device domains.
JO
Jean OrthNamed on SEC filing
MM
Mariam MaghribiNamed on SEC filing
Board
CG
Casey GordonBoard director
CS
Christopher ShenBoard director
BC
Bihua ChenBoard director
AS
Amr SalahiehBoard director
Investors · 8
415 Capital✓ confirmed by Supira MedicalMunich · $5.4M – $16.2M
How we know: 415 Capital's portfolio page · the company's own site · funding news · press coverage · Not right? Tell us
Amed Ventures✓ confirmed by Supira MedicalLewes
How we know: the company's own site · funding news · press coverage · Not right? Tell us
The Capital Partnership✓ confirmed by Supira MedicalLondon
How we know: the company's own site · Not right? Tell us
Unorthodox Ventureslisted by Unorthodox VenturesAustin · $1M – $5M
How we know: Unorthodox Ventures's portfolio page · press coverage · Not right? Tell us
Novo HoldingsreportedCopenhagen · $1.1M – $54M
How we know: funding news · third-news.com · Not right? Tell us
Also in the syndicate · 2
Cormorant Asset ManagementThe Capital Partnership (TCP)
Reported raises · per SEC filings
Form D private placements$220.7M disclosed across 6 rounds · 2017–2025
▶$120MraisedApr 2025 · 20 investors · Other Health CareRule 506(b)
▶$120MraisedApr 2025 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nitin SalunkeExecutive Officer, Director
- Casey GordonDirector
- Christopher ShenDirector
- Amr SalahiehDirector
- Bihua ChenDirector
- Offering amount
- $120M
- Amount sold
- $120M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$21.1MraisedDec 2023 · 22 investors · Other Health CareRule 506(b)
▶$21.1MraisedDec 2023 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nitin SalunkeExecutive Officer, Director
- Bihua ChenDirector
- Amr SalahiehDirector
- Casey GordonDirector
- Offering amount
- $40M
- Amount sold
- $21.1M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30MraisedMar 2022 · 31 investors · Other Health CareRule 506(b)
▶$30MraisedMar 2022 · 31 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nitin SalunkeExecutive Officer, Director
- Casey GordonDirector
- Amr SalahiehDirector
- Bihua ChenDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35.1MraisedMar 2020 · 31 investors · OtherRule 506(b)
▶$35.1MraisedMar 2020 · 31 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Amr SalahiehDirector
- Casey GordonDirector
- Bihua ChenDirector
- Nitin SalunkeExecutive Officer, Director
- Offering amount
- $35.1M
- Amount sold
- $35.1M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12.9MraisedMay 2018 · 24 investors · OtherRule 506(b)
▶$12.9MraisedMay 2018 · 24 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Amr SalahiehDirector
- Casey GordonDirector
- Mariam MaghribiExecutive Officer
- Jean OrthExecutive Officer, Director
- Offering amount
- $12.9M
- Amount sold
- $12.9M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedDec 2017 · 15 investors · OtherRule 506(b)
▶$1.6MraisedDec 2017 · 15 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Amr SalahiehDirector
- Jean OrthExecutive Officer
- Mariam MaghribiExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.6M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 6
Aviary HealthAviary Health provides virtual and hybrid clinical programs — including cardiac rehabilitation, pulmonary rehabilitation, and chronic care management — combining AI-powered workflows with clinical teams. It serves hospitals and health systems, delivering end-to-end support for complex service lines.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Insightra MedicalInsightra Medical develops intra-aortic balloon pump (IABP) catheters used to temporarily support heart function, including a 7Fr IAB catheter kit compatible with Arrow and Datascope consoles. The products are FDA-cleared medical devices intended for use by medical professionals in cardiac catheterization settings.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
SyncardiaSynCardia manufactures the world's first commercially approved total artificial heart for patients with end-stage heart failure awaiting transplant. The company develops and delivers mechanical circulatory support devices as alternatives to heart transplantation for critically ill patients.
ToperaAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Companies working in the same space as Supira Medical.
In the news
Frequently asked questions
- What does Supira Medical do?
- Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock. It is a cardiovascular medical device company formed by the Shifamed innovation hub.
- Who are Supira Medical's investors?
- Supira Medical's investors include 415 Capital, Amed Ventures, The Capital Partnership, Unorthodox Ventures, Novo Holdings, Qatar Investment Authority.
- How much funding has Supira Medical raised?
- Supira Medical has disclosed $220.7M raised across 6 rounds.
- Where is Supira Medical headquartered?
- Supira Medical is headquartered in Campbell, US.